Here is some info I put together about rotavirus for some other people. I cut and pasted so not how well it will turn out looking:
RotaTeq is one of the rotovirus vaccines (approved in 2006) and
below is the package insert link. There is another one that just
came out called Rotarix (approved in 2008).
http://www.merck.com/product/usa/pi_...rotateq_pi.pdf
It says "Most common adverse events included diarrhea, vomiting,
irritability, otitis media (ear infection), nasopharyngitis, and
bronchospasm."
Below is the link to VAERS and if you search under the vaccine
ROTHB5 you can see what has been reported to VAERS on this vaccine.
http://www.medalerts.org/vaersdb/http://www.merck.com/product/usa/pi_...rotateq_pi.pdf
From the package insert:
"5.4 Shedding and Transmission
Shedding was evaluated among a subset of subjects in REST 4 to 6
days after each dose and among
all subjects who submitted a stool antigen rotavirus positive sample
at any time. RotaTeq was shed in the
stools of 32 of 360 [8.9%, 95% CI (6.2%, 12.3%)] vaccine recipients
tested after dose 1; 0 of 249 [0.0%,
95% CI (0.0%, 1.5%)] vaccine recipients tested after dose 2; and in
1 of 385 [0.3%, 95% CI (<0.1%,
1.4%)] vaccine recipients after dose 3. In phase 3 studies, shedding
was observed as early as 1 day and
as late as 15 days after a dose. Transmission was not evaluated.
Caution is advised when considering whether to administer RotaTeq to
individuals with
immunodeficient close contacts such as:
• Individuals with malignancies or who are otherwise
immunocompromised; or
• Individuals receiving immunosuppressive therapy.
RotaTeq is a solution of live reassortant rotaviruses and can
potentially be transmitted to persons who
have contact with the vaccine. The potential risk of transmission of
vaccine virus should be weighed
against the risk of acquiring and transmitting natural rotavirus."
http://jama.ama-assn.org/cgi/content/full/279/17/1371
" Finally, about 20 deaths occur each year due to rotavirus diarrhea
among children younger than 5 years,1, 6 for a cumulative incidence
by age 5 years of 0.000005 (1 in 195000 children)."
I also found this interesting, from:
http://www.ncbi.nlm.nih.gov/sites/entrez?
db=pubmed&uid=11069230&cmd=showdetailview&indexed= google
"To determine whether naturally acquired serum IgA and IgG
antibodies were associated with protection against rotavirus
infection and illness, a cohort of 200 Mexican infants was monitored
weekly for rotavirus excretion and diarrhea from birth to age 2
years. Serum samples collected during the first week after birth and
every 4 months were tested for anti-rotavirus IgA and IgG. Children
with an IgA titer >1:800 had a lower risk of rotavirus infection
(adjusted relative risk [aRR], 0.21; P<.001) and diarrhea (aRR, 0.
16; P=.01) and were protected completely against moderate-to-severe
diarrhea. However, children with an IgG titer >1:6400 were protected
against rotavirus infection (aRR, 0.51; P<.001) but not against
rotavirus diarrhea. Protective antibody titers were achieved after 2
consecutive symptomatic or asymptomatic rotavirus infections. These
findings indicate that serum anti-rotavirus antibody, especially
IgA, was a marker of protection against rotavirus infection and
moderate-to-severe diarrhea."
What I got from this is that the body gains
immunity from rotovirus infection and the diarrhea after having a
couple exposures to rotovirus, regardless of whether they get sick
from the rotovirus. So like with many other sicknesses, allowing the
body to deal with rotovirus, actually helps the body with future
sicknesses.
Also some good info to know. There is alot of info to learn here (so I would
read from the following link if you have time), but I will just
include a little bit here. It also says at the beginning that they
estimate that acute diarrhea accounts for 300 deaths per year in the
US, and from earlier in my post, only 20 of those would be from
rotovirus.
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5216a1.htm
"Home Management of Acute Diarrhea
Treatment with ORS is simple and enables management of uncomplicated
cases of diarrhea at home, regardless of etiologic agent. As long as
caregivers are instructed properly regarding signs of dehydration or
are able to determine when children appear markedly ill or appear
not to be responding to treatment, therapy should begin at home.
Early intervention can reduce such complications as dehydration and
malnutrition. Early administration of ORS leads to fewer office,
clinic, and emergency department (ED) visits (37) and to potentially
fewer hospitalizations and deaths."
*ORS being oral rehydration solutions such as pedialyte. Breastfed
infants should continue nursing on demand.
So the bottom line on rotavirus, in my opinion, is that while there are alot of cases of rotavirus, very few children die from it, and most will not even need to go to the hospital if proper precautions are taken at home. The symptoms of the disease are almost the same as the common adverse events from the vaccine. The vaccine can shed to others.